Oncopeptides AB (publ) (LON:0RN4)
London · Delayed Price · Currency is GBP · Price in SEK 5.39
+0.14 (2.67%)
At close: Dec 5, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 116.26 million as of December 5, 2025. Its market cap has increased by 420.86% in one year.
Market Cap
116.26M
Enterprise Value
116.33M
Revenue
4.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.39
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 116.26M, a decrease of -22.01%. That is a compound annual growth rate of -2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 116.26M | 379.91% |
| Dec 30, 2024 | 24.23M | -57.05% |
| Dec 29, 2023 | 56.41M | -38.17% |
| Dec 30, 2022 | 91.23M | 76.11% |
| Dec 30, 2021 | 51.80M | -94.99% |
| Dec 30, 2020 | 1.03B | 80.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 182.10B |
| Shell | 158.55B |
| Unilever | 110.94B |
| Rio Tinto Group | 94.53B |
| British American Tobacco p.l.c. | 93.13B |
| Rolls-Royce Holdings | 90.78B |
| GSK plc | 72.47B |